DAWN

Day One Biopharmaceuticals, Inc.

13.56 USD
-0.12 (-0.88%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Day One Biopharmaceuticals, Inc. stock is down -1.53% since 30 days ago. The next earnings date is Aug 5, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 June’s closed higher than May. In the last 5 Unusual Options Trades, there were 3 CALLs, 2 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
01 May 15:34 17 May, 2024 17.50 CALL 491 1118
01 May 16:42 17 Jan, 2025 15.00 CALL 100 190
15 May 18:08 21 Jun, 2024 15.00 CALL 199 642
04 Jun 16:23 18 Oct, 2024 12.50 PUT 150 1
04 Jun 16:38 18 Oct, 2024 12.50 PUT 199 1

About Day One Biopharmaceuticals, Inc.

Day One Biopharmaceuticals, Inc. develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor.

  • HC Wainwright & Co.
    Thu Jun 20, 06:10
    buy
    confirm
  • Needham
    Wed Jun 19, 05:35
    buy
    confirm